Mologic made media headlines in The Mail Online.

MailOnline

Mologic is developing a simple urinary test, HEADStart, to help COPD patients manage their disease at home.

It was recently featured in Mail Online.

Headstart

A 63-year old who tested the product described his experience::
“‘The testing kit is a benefit no-end as you are able to predict a possible attack, which allows you to take medicine before it becomes nasty”.

Click the link below to find out more:

http://www.dailymail.co.uk/health/article-4456024/Could-urine-test-save-thousands-lives.html

Mologic is a leading developer of lateral flow and rapid diagnostic technologies, products and services. We work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care.

Our Co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test. Launched in 1988, it was the world’s first commercial application of lateral flow technology. The creativity, insight and knowledge that led to that ground-breaking invention has guided Mologic since our formation in 2003.